Histamine H-1 receptor ligands Part II. Synthesis and in vitro pharmacology of 2-[2-(phenylamino)thiazol-4-yl]ethanamine and 2-(2-benzhydrylthiazol-4-yl)ethanamine derivatives

Citation
K. Walczynski et al., Histamine H-1 receptor ligands Part II. Synthesis and in vitro pharmacology of 2-[2-(phenylamino)thiazol-4-yl]ethanamine and 2-(2-benzhydrylthiazol-4-yl)ethanamine derivatives, FARMACO, 55(9-10), 2000, pp. 569-574
Citations number
18
Categorie Soggetti
Pharmacology & Toxicology
Journal title
FARMACO
ISSN journal
0014827X → ACNP
Volume
55
Issue
9-10
Year of publication
2000
Pages
569 - 574
Database
ISI
SICI code
0014-827X(200009/10)55:9-10<569:HHRLPI>2.0.ZU;2-U
Abstract
New 2-[2-(phenylamino)thiazol-4-yl]ethanamine and 2-(2-benzhydrylthiazol-4- yl)ethanamine derivatives were prepared and tested in vitro as H-1 receptor antagonists. The compounds with 2-phenylamino substitution with meta-halid e substituents at the phenyl ring, showed weak H-1-antagonistic activity (p A(2): 4.62-5.04) and this activity was completely lost in the case of meta- methyl substituent (pA(2) < 4). When the phenylamino group was replaced by benzhydryl groups of classic antihistamines, the resulting compounds exhibi ted slightly improved H-1-antagonistic activity (at the meta-position pA(2) : 6.38-6.15; at the para-position pA(2): 6.04-5.87). (C) 2000 Elsevier Scie nce S.A. All rights reserved.